Search
forResearch 10 of 1000+
- Evolving CRBN ligands enhance the drug-like properties of protein degraders
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Hair loss with antidepressants
- Antidepressant-like effect of fluoxetine may depend on translocator protein activity and pretest session duration in forced swimming test in mice
- α1A-blockers's combined with prozac for the treatment of premature ejaculation
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- American College of Veterinary Behaviorists 2003 Scientific Session Abstracts
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Hair Loss after Rhytidectomy
Community 4 of 9
- DHT and 5AR respect post, it's importance within the brain
- Allopregnanolone deficiency by 5-ari inhibition (fin/dut users)
- Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China
- GT20029 China Phase II Trial For AGA Reached Primary Endpoint
Learn
— no results
Try a deeper search in learn →